BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11713570)

  • 1. Ultrastructural and biosynthetic characteristics of epidermal cells in patients with psoriasis treated with antiproliferative drugs.
    Krinitsyna YM; Nepomnyashchikh GI; Aidagulova SV
    Bull Exp Biol Med; 2001 Aug; 132(2):797-802. PubMed ID: 11713570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light and electron microscopy of psoriatic skin before and during retinoid (Ro 10-9359) and retinoid-PUVA treatment.
    Kanerva L; Lauharanta J; Niemi KM; Lassus A
    J Cutan Pathol; 1982 Jun; 9(3):175-88. PubMed ID: 7130503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis.
    Ellis CN; Gold RC; Grekin RC; Anderson TF; Swanson NA; Voorhees JJ
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):699-704. PubMed ID: 7068978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of photochemotherapy on epidermal-glycogen and on capillaries in psoriatic skin.
    Vukas A; Batistić B; Velfl D
    Dermatologica; 1978; 157(2):86-90. PubMed ID: 668974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug eruption caused by nitrazepam in a patient with severe pustular psoriasis successfully treated with methotrexate and etretinate.
    Shoji A; Kitajima J; Hamada T
    J Dermatol; 1987 Jun; 14(3):274-8. PubMed ID: 2959694
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M; Paravicini U
    J Am Acad Dermatol; 1984 Apr; 10(4):632-8. PubMed ID: 6715613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralen photochemotherapy of psoriasis.
    Hell E; Hodgson C; Manna V
    Br J Dermatol; 1979 Sep; 101(3):293-8. PubMed ID: 508595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study.
    Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC
    Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histidine-rich protein synthesis in the mouse epidermis in the early periods after stimulation of epidermocyte proliferation and the effect of chalones].
    KetlinskiÄ­ SA; Parfenova EV
    Tsitologiia; 1981 Dec; 23(12):1395-402. PubMed ID: 6460364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis associated with opisthorchiasis under conditions of anthelmintic therapy.
    Nepomnyashchikh LM; Aidagulova SV; Senchukova SR; Voronova NA
    Bull Exp Biol Med; 2004 Apr; 137(4):407-10. PubMed ID: 15452616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
    Kaplan RP; Russell DH; Lowe NJ
    J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
    Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
    Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of protein-DNA association in chromatin from epidermal cells in psoriasis].
    Iagovdik NZ; Fedorova TA; Detinkin ON
    Vopr Med Khim; 1987; 33(2):62-4. PubMed ID: 3604143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and etretinate in the treatment of psoriasis.
    Vanderveen EE; Ellis CN
    Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
    Rosenbaum MM; Roenigk HH
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):357-61. PubMed ID: 6707259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris.
    Iwakiri K; Ghazizadeh M; Jin E; Fujiwara M; Takemura T; Takezaki S; Kawana S; Yasuoka S; Kawanami O
    J Invest Dermatol; 2004 Apr; 122(4):937-44. PubMed ID: 15102084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.